Twaao Exchange Achieves ISO 27001 International Security Certification,...
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Recently, Twaao Exchange successfully obtained the ISO 27001 international information security management system certification. This certification...
View ArticleBlack Kite Announces Court Dismissal of Bitsight Technologies’ Patent Claims...
Federal Court Rules that Bitsight’s Asserted Patent Claims are Invalid Federal Court Rules that Bitsight’s Asserted Patent Claims are Invalid
View ArticleCayosoft Wins Patent for Revolutionary Instant Active Directory Recovery...
Guardian Forest Recovery restores Active Directory instantly to ensure business continuity in the face of escalating ransomware attacks Guardian Forest Recovery restores Active Directory instantly to...
View ArticleTevogen Bio Leadership Meets Members of U.S. Congress to Advocate for Long...
WARREN, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
View ArticleNuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the...
EDINBURGH, United Kingdom, Sept. 25, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering...
View ArticleCD47 Targeted Cancer Immunotherapy Drugs Clinical Trials FDA Approval Insight
First CD47 Targeting Drug Is Expected To Be Approved By 2029 Says Kuick Research First CD47 Targeting Drug Is Expected To Be Approved By 2029 Says Kuick Research
View ArticleGlobal Bispecific Antibodies Clinical Trials Market Size FDA Approved...
Global Bispecific Antibodies Market Is Estimated To Surpass USD 40 Billion By 2029 Says Kuick Research In Recent Report Global Bispecific Antibodies Market Is Estimated To Surpass USD 40 Billion By...
View ArticleImpact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue
HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...
View ArticleWearable Devices Expands its International IP Portfolio with Filed Patent...
The new patent application, filed as part of the Patent Cooperation Treaty (PCT) national stage, aims to protect the Company’s global patent portfolio in the Asian markets
View ArticleTonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the...
New patent expected to provide market exclusivity into 2036
View ArticleAnnovis Files Three New Patents for Combination Therapies Involving...
MALVERN, Pa., Sept. 30, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company developing transformative therapies...
View ArticleComputing Systems Containing Certain Power Modules Infringe Vicor Patents
Initial Determination from the U.S. International Trade Commission Initial Determination from the U.S. International Trade Commission
View ArticleBioVie Receives Notice of Allowance for United States Patent Application...
Patents covering BioVie’s terlipressin liquid formulation now secured in the United States, India and Chile, and are pending in nine additional markets
View ArticleFlexShopper Files Patent Infringement Lawsuits Against Upbound Group, Inc....
BOCA RATON, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- FlexShopper, Inc. (Nasdaq: FPAY), (“the Company”), a leading online lease-to-own retailer and payment solutions provider, has initiated legal action...
View ArticleInterDigital signs new license agreements with TPV
WILMINGTON, Del., Oct. 01, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company has signed...
View ArticleMyriad Genetics Announces Third Patent Granted for Molecular Residual Disease...
SALT LAKE CITY, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark...
View ArticleElevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent...
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients,
View ArticleREPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent...
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients,
View ArticleAnti CD70 Antibodies Clinical Trials FDA Approval CD70 Cancer Therapies...
Currently more Than 20 CD70 Targeting Therapies In Clinical Trials Are Clinical Trials Says Kuick Research Currently more Than 20 CD70 Targeting Therapies In Clinical Trials Are Clinical Trials Says...
View ArticleGlobal mRNA Cancer Vaccine Clinical Trial FDA Approval Market Size Future...
First commercial Approval Of mRNA Cancer Vaccine Is Expected In Near Future Says Kuick Research First commercial Approval Of mRNA Cancer Vaccine Is Expected In Near Future Says Kuick Research
View Article